Skip to main content

MAVERICK CAPITAL LTD

Position in WVE — Wave Life Sciences, Inc.

CIK 934639 DALLAS, TX

Position in WVE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$59,715,848
-$13,954,294 QoQ
Shares Held
10,278,115
+1.1% QoQ
Ownership
5.22%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#4
of 237 holders
Holding Since
Mar 2021
22 quarters on record

Common Shares in WVE Over Time

Shares Held

Position Value (USD)

Derivatives in WVE

reported options exposure · as of Mar 31, 2026
CallValue
$8,381,000
CallShares
1,156,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MAVERICK CAPITAL LTD holds $942,556,118 across 15 Biotechnology names. WVE ranks #8 (6.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 WVE
Wave Life Sciences, Inc.
This page
10,278,115 $59,715,848

All Filings in WVE

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $59,715,848 10,278,115
2026-03-31 $8,381,000 1,156,000
2026-03-31 $73,670,142 10,161,399
2025-12-31 $6,460,000 380,000
2025-12-31 $157,764,029 9,280,237
2025-09-30 $2,781,600 380,000
2025-09-30 $61,428,385 8,391,856
2025-06-30 $53,700,939 8,261,683
2025-06-30 $2,318,550 356,700
2025-03-31 $66,754,398 8,261,683
2024-12-31 $102,191,563 8,261,242
2024-12-31 $102,191,563 8,261,242
2024-09-30 $82,389,664 10,047,520
2024-06-30 $38,270,111 7,669,361
2024-03-31 $47,435,447 7,688,079
2023-12-31 $42,661,410 8,447,804
2023-09-30 $37,917,334 6,594,319
2023-06-30 $24,012,271 6,596,778
2023-03-31 $28,564,048 6,596,778
2022-12-31 $49,683,648 7,097,664
2022-09-30 $28,176,840 7,805,219
2022-06-30 $25,366,961 7,805,219
2022-03-31 $11,186,778 5,593,389
2021-12-31 $17,563,241 5,593,389
2021-09-30 $15,647,606 3,193,389
2021-06-30 $20,566,952 3,088,131
2021-03-31 $17,296,757 3,083,201